InterVenn Investigator Initiated Research Program in Glycoproteomics

"Fucose signatures in peripheral blood glycoproteins are associated with reduced clinical benefit of immune-checkpoint inhibitors in metastatic melanoma"

— Society for Glycobiology 2022

"Circulating glycopeptide markers differentiate between early- and late-stage epithelial ovarian cancer"

— Society for Glycobiology 2022

"Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma"

— J. Proteome Res. 2022, 21, 1083−1094, Peer-Reviewed Article

"Clinicians' Perspective on Use of Immune Checkpoint Inhibitors and Related Biomarkers for Solid Tumors"

— British Journal of Cancer Research 2022;5(1): 550 – 557, Peer-Reviewed Article

"Serum glycoproteomic signatures predict overall survival in bone and soft tissue sarcoma patients treated with immune checkpoint inhibitor therapy"

— American Society of Clinical Oncology (ASCO) 2022, Poster

"Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment benefit in metastatic malignant melanoma"

— American Society of Clinical Oncology (ASCO) 2022, Poster

"Liquid-biopsy-derived Glycoproteomic Profiling as a Novel Means for Noninvasive Diagnosis of Ovarian Cancer."

— American Society of Clinical Oncology (ASCO) 2022, Online Abstract

"Glycoproteomics as a powerful liquid biopsy-based screening tool for non-small cell lung cancer."

— American Society of Clinical Oncology (ASCO) 2022, Online Abstract

"Clinicians’ perspective on use of immune checkpoint inhibitors and related biomarkers for solid tumors."

— American Society of Clinical Oncology (ASCO) 2022, Online Abstract

"Identifying potential glycoproteomic biomarkers for diagnosis of colorectal cancer."

— American Society of Clinical Oncology (ASCO) 2022, Online Abstract

"Predicting breast cancer in women using liquid biopsy-derived glycoproteomic markers."

— American Society of Clinical Oncology (ASCO) 2022, Online Abstract

"Peripheral Blood Glycoproteomic Biomarkers As A Powerful New Tool For The Detection Of Nasopharyngeal Carcinoma"

— Association for Cancer Research (AACR) 2022 , Abstract

"Glycoproteomics-based Liquid Biopsy Informs Optimal Checkpoint-inhibitor Drug Choice"

— Association for Cancer Research (AACR) 2022 , Abstract

"Novel Plasma Glycoprotein Biomarkers Predict Progression-Free Survival In Surgically Resected Clear Cell Renal Cell Carcinoma"

— Urologic Oncology: Seminars and Original Investigations

"Differential Peripheral Blood Glycoprotein Profiles In Symptomatic And Asymptomatic COVID-19"

— Viruses

"30 Blood-Based Glycoprotein Signatures In Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Receiving First-Line Immune Checkpoint Blockade"

— BMJ Publishing Group Ltd

"Differential Glycoprotein Profiles In Severe And Asymptomatic COVID-19"

— American Society for Mass Spectrometry, 2021

"Serum Glycoprotein Markers In Non-Alcoholic Steatohepatitis And Hepatocellular Carcinoma"

— bioRxiv

"Glycoproteomics As A Powerful Liquid Biopsy-Based Predictor Of Checkpoint-Inhibitor Treatment Response"

— American Association for Cancer Research

"Site-Specific Glycosylation Quantitation Of 50 Serum Glycoproteins Enhanced By Predictive Glycopeptidomics For Improved Disease Biomarker Discovery"

— Analytical Chemistry, 2019

"PB-Net: Automatic Peak Integration By Sequential Deep Learning For Multiple Reaction Monitoring"

— ScienceDirect

"Serum Glycoproteomic-Based Liquid Biopsy For The Detection Of Pancreatic Ductal Adenocarcinoma."

— Journal of Clinical Oncology